DuPont Decomposition

Why does RADIOCITY earn its ROE?

Breaking down Return on Equity into profitability, efficiency, and leverage.

ROE = Net Margin × Asset Turnover × Equity Multiplier

-12.0% = -30.6% × 0.35 × 1.11

Latest: FY2026

Profitability

Net Margin

-30.6%

-3.4% →-30.6%

How much profit per ₹ of revenue

Efficiency

Asset Turnover

0.35x

0.26x →0.35x

Revenue per ₹ of assets

Leverage

Equity Multiplier

1.11x

1.08x →1.11x

Assets funded by equity vs debt

Trend Analysis

ROE declined by 11.0 pp over 5 years. Driven by net margin declining (-3.4% → -30.6%).

Historical Decomposition

Last 5 years

YearRevenuePATNet MarginAsset TOLeverageROE
FY20220Cr-0Cr-3.4%0.261.08-0.9%
FY20230Cr0Cr1.7%0.301.250.7%
FY20240Cr0Cr3.0%0.341.281.3%
FY20250Cr-0Cr-14.4%0.351.34-6.8%
FY20260Cr-0Cr-30.6%0.351.11-12.0%

How to read DuPont

  • Rising ROE from margin = pricing power, operational improvement (good)
  • Rising ROE from turnover = better asset utilization (good)
  • Rising ROE from leverage = more debt, amplified risk (caution)
  • Falling ROE across all three = structural deterioration (red flag)

See DCF fair value for RADIOCITY

Combine financial quality with intrinsic value.

See Fair Value →

DuPont decomposition from audited annual financials. Factual analysis, not investment advice.

RADIOCITY DuPont Analysis — ROE -12.0% | YieldIQ